130 related articles for article (PubMed ID: 15800941)
21. In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoral hypercalcemia of cancer.
Yamato H; Nagai Y; Inoue D; Ohnishi Y; Ueyama Y; Ohno H; Matsumoto T; Ogata E; Ikeda K
J Bone Miner Res; 1995 Jan; 10(1):36-44. PubMed ID: 7747629
[TBL] [Abstract][Full Text] [Related]
22. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
[TBL] [Abstract][Full Text] [Related]
23. Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.
Kukreja SC; Rosol TJ; Wimbiscus SA; Shevrin DH; Grill V; Barengolts EI; Martin TJ
Endocrinology; 1990 Jul; 127(1):305-10. PubMed ID: 2361475
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
25. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-2 increases production and secretion of parathyroid hormone-related peptide by human T cell leukemia virus type I-infected T cells: possible role in hypercalcemia associated with adult T cell leukemia.
Ikeda K; Okazaki R; Inoue D; Ohno H; Ogata E; Matsumoto T
Endocrinology; 1993 Jun; 132(6):2551-6. PubMed ID: 8099324
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
[TBL] [Abstract][Full Text] [Related]
28. Histopathological study of time course changes in PTHrP-induced incisor lesions of rats.
Kato A; Suzuki M; Karasawa Y; Sugimoto T; Doi K
Toxicol Pathol; 2005; 33(2):230-8. PubMed ID: 15902966
[TBL] [Abstract][Full Text] [Related]
29. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
Niizuma H; Fujii K; Sato A; Fujiwara I; Takeyama J; Imaizumi M
Pediatr Blood Cancer; 2007 Dec; 49(7):990-3. PubMed ID: 16496289
[TBL] [Abstract][Full Text] [Related]
30. [Cytokines in bone diseases. Cytokines and malignancy-associated hypercalcemia].
Okazaki R
Clin Calcium; 2010 Oct; 20(10):1497-502. PubMed ID: 20890031
[TBL] [Abstract][Full Text] [Related]
31. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
[TBL] [Abstract][Full Text] [Related]
32. Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice.
Miki T; Yano S; Hanibuchi M; Sone S
Oncol Res; 2000; 12(5):209-17. PubMed ID: 11417746
[TBL] [Abstract][Full Text] [Related]
33. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
34. Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen.
Iguchi H; Onuma E; Sato K; Sato K; Ogata E
Int J Cancer; 2001 Oct; 94(1):24-7. PubMed ID: 11668474
[TBL] [Abstract][Full Text] [Related]
35. [Mechanism of hypercalcemia associated with malignancy: interactions between induction of hypercalcemia and autonomous growth in VX2 cancer cells].
Kato I
Osaka Daigaku Shigaku Zasshi; 1989 Jun; 34(1):142-73. PubMed ID: 2637347
[TBL] [Abstract][Full Text] [Related]
36. Serum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor Burden.
Hong N; Yoon HJ; Lee YH; Kim HR; Lee BW; Rhee Y; Kang ES; Cha BS; Lee HC
J Clin Endocrinol Metab; 2016 Mar; 101(3):1207-14. PubMed ID: 26765580
[TBL] [Abstract][Full Text] [Related]
37. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
Aklilu F; Park M; Goltzman D; Rabbani SA
Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
[TBL] [Abstract][Full Text] [Related]
38. Regulation of parathyroid hormone-related protein production by a squamous carcinoma cell line in vitro.
Merryman JI; Capen CC; McCauley LK; Werkmeister JR; Suter MM; Rosol TJ
Lab Invest; 1993 Sep; 69(3):347-54. PubMed ID: 8377475
[TBL] [Abstract][Full Text] [Related]
39. Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels.
Takahashi S; Hakuta M; Aiba K; Ito Y; Horikoshi N; Miura M; Hatake K; Ogata E
Endocr Relat Cancer; 2003 Sep; 10(3):403-7. PubMed ID: 14503917
[TBL] [Abstract][Full Text] [Related]
40. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
Gaich G; Burtis WJ
Endocrinology; 1990 Sep; 127(3):1444-9. PubMed ID: 2387260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
